Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety.
In this paper, we will give an overview of the background for the possible effects of long-chain marine n-3 (synonymously called omega-3) polyunsaturated fatty acids (PUFA) in coronary heart disease (CHD) with focus on recent findings. In a forthcoming paper, we will focus on the clinical trial data, current recommendations and suggest trials to further study the role of marine n-3 PUFA in the prevention and treatment of CHD.
Schmidt
Erik Berg
EB
Department of Preventive Cardiology, Aalborg Sygehus, Arhus University Hospitals, Arhus, Denmark. ebs@aas.nja.dk
Arnesen
Harald
H
de Caterina
Raffaele
R
Rasmussen
Lars Hvilsted
LH
Kristensen
Steen Dalby
SD
D000818:Animals; D003327:Coronary Disease / Q000453:epidemiology* / Q000517:prevention & control; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry; D005395:Fish Oils / Q000008:administration & dosage; D005399:Fishes; D006801:Humans; D012307:Risk Factors
D015525:Fatty Acids, Omega-3; D005395:Fish Oils